NUWELLIS NUWE 深 沪
交易中 02-03 09:52:32 美东时间
4.075
+0.225
+5.84%
华盛通- 最 高4.10
- 今 开3.83
- 成交量 2.34万股
- 最 低 3.83
- 昨 收 3.85
- 总市值 367.85万
- 52周最高 62.16
- 市盈率 静 --
- 换手率 2.59%
- 52周最低 1.709
- 委 比 97.71%
- 总股本 90.27万
- 历史最高 2012724000.00
- 量 比 0.05
- 振 幅 7.01%
- 历史最低 1.709
- 每 手 1
- 风险率 19.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nuwellis Appoints Carisa Schultz CFO, Effective Feb. 2
Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026.Ms.
01-30 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 81.5% to $3.9 during Tuesday's regu...
01-28 01:05
Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare
Nuwellis Inc (NASDAQ:NUWE) saw its stock soar over 100% in pre-market trading amid a boardroom shakeup and a new pediatric USPTO patent.
01-28 00:14
BRIEF-Nuwellis Announces Changes To Board Of Directors
BRIEF-Nuwellis Announces Changes To Board Of Directors Jan 23 (Reuters) - Nuwellis Inc NUWE.O : NUWELLIS ANNOUNCES CHANGES TO BOARD OF DIRECTORS Source text: ID:nGNX56WvHq Further company coverage: NUWE.O (( Reuters.Briefs@thomsonreuters.com ;))
01-24 05:51
Nuwellis Granted New Patent From U.S. Patent And Trademark Office For Advanced Safety Mechanisms For Blood Return Line Clamps Used In Extracorporeal Blood Filtration Systems
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum today announced that the United States Patent and Trademark Office recently
01-06 21:17
Nuwellis Announces A Leading Northeastern U.S. Children's Hospital Has Initiated An Aquadex Ultrafiltration Program
Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children's hospital has initiated
2025-12-04 21:16
Nuwellis Q3 EPS $0.56 Beats $(0.41) Estimate, Sales $2.217M Miss $2.500M Estimate
Nuwellis (NASDAQ:NUWE) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $(0.41) by 236.59 percent. This is a 99.24 percent decrease over earnings of $73.23 per share from the
2025-11-12 21:18
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
Nuwellis Receives Notice Of Allowance For New Patent Covering Advanced Safety Mechanisms For Blood Return Line Clamps Used In Extracorporeal Blood Filtration Systems, Including Vivian Pediatric CRRT System
Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys, today announced
2025-11-10 22:09
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
<p>Nuwellis Inc., a medical technology company focused on cardio-renal conditions, will release its Q3 2025 financial results on November 12, 2025. A conference call and webcast will be held at 9:00 AM ET to discuss the results and provide a business update. Investors can access the webcast via <a href="https://ir.nuwellis.com">https://ir.nuwellis.com</a> or join the call by dialing 1-800-274-8461 (U.S.) or 1-203-518-9814 (int'l) with conference ...
2025-10-23 13:00
